Cancer screening with FDG-PET

Thi study is based on medical health check-up and cancer screening on of a medical health club using PET, MRI, spiral CT and other conventional examinations. Between October 1994 and June 2005, 9,357 asymptomatic members of the health club participated in 24,772 screening session (5,693 men and 3,66...

Full description

Saved in:
Bibliographic Details
Published inThe quarterly journal of nuclear medicine and molecular imaging Vol. 50; no. 1; pp. 23 - 27
Main Author Ide, M
Format Journal Article
LanguageEnglish
Published Italy Edizioni Minerva Medica 01.03.2006
Subjects
Adolescent
Adult
Aged
Aged, 80 and over
Cancer
Female
Fluorodeoxyglucose F18
Humans
Incidence
Japan - epidemiology
Male
Medical screening
Middle Aged
Neoplasms - diagnostic imaging
Neoplasms - epidemiology
NMR
Nuclear magnetic resonance
Nuclear medicine
Positron-Emission Tomography - statistics & numerical data
Radiopharmaceuticals
Reproducibility of Results
Risk Assessment - methods
Risk Factors
Sensitivity and Specificity
Tomography
Tumors
Whole Body Imaging - statistics & numerical data
Online AccessGet full text

Cover

More Information
Summary:Thi study is based on medical health check-up and cancer screening on of a medical health club using PET, MRI, spiral CT and other conventional examinations. Between October 1994 and June 2005, 9,357 asymptomatic members of the health club participated in 24,772 screening session (5,693 men and 3,664 women, mean age was 52.2+/-10.4 years). Malignant tumors were discovered in 296 of the 9,357 participants (3.16%) and 24,772 screening sessions (1.19%). The detection rate of our program is much higher than that of mass screening in Japan. The thyroid, lung, colon and breast cancers were PET positive, but the prostate, renal and bladder cancers were generally PET negative. FDG-PET has the potential to detect a wide variety of cancers at curable stages in asymptomatic individuals. To reduce false-positive and false-negative results of PET examination, there is a need for experienced radiologist and/or oncologists who had training in the wide aspect of FDG-PET. FDG-PET has limitations in the detection of urological cancers, cancers of low cell density, small cancers and hypometabolic or FDG non-avid cancers. Therefore, conventional examinations and/or PET/CT are also needed for cancer screening in association with FDG-PET.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:1824-4785
1827-1936